downgrade

Will U.S. Downgrade Bring On a Bear Market?

Standard & Poor's downgraded the U.S. debt rating for the first time on Friday. Coming on top of concerns of a second recession, the move has investors worried that we're headed into a bear market for stocks. Here's what a bear market would mean.

The Financial Landscape: Moody's Mulls Debt Ceiling

Looks like rough sailing ahead: Moody's warned the GOP that its game of chicken with the debt ceiling risked a downgrade of U.S. debt, and the Labor Department said May hiring took a dive. But there are some things investors can look forward to: a Groupon IPO, and the government selling its last shares of Chrysler.

Moody's Downgrades Hungary to Near Junk

Moody's downgrades Hungary's sovereign credit rating by two notches to near junk on concern that the temporary measures the government is taking to address budget issues won't be sustainable.

Moody's Warns It May Cut Ireland's Credit Rating

Less than a week after downgrading Spain's credit rating, Moody's Investors Service warned it might cut Ireland's credit rating as well. Moody's said its decision to review Ireland's rating was prompted by the government's announcement last week that it was pledging more money -- as much as %u20AC50 billion -- to save the country's banks, as well as the weak economic recovery and rising borrowing costs.

Intel and HP Downgraded on Weak Demand

Shares of computer makers Intel Corp. and Hewlett-Packard Co. were downgraded by UBS amid concerns that weak demand will force the companies to dramatically cut prices.

Vivus Hammered After FDA Panel's 'No' Vote

Pharmaceutical company Vivus is getting hammered in premarket trading, sinking more than 50% to around $5.32 in the wake of Thursday's vote by an FDA advisory panel against approving its weight-loss drug, Qnexa, based on safety concerns.

Biz Brief: Analysts Weigh In on CVS, Walgreen Dispute

Earlier this week, CVS Caremark said it will exclude Walgreen from its pharmacy network following a dispute between the two. The decision is a risk to both companies, but analysts have appeared more concerned about its impact on Walgreen.